Log in to save to my catalogue

Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia sy...

Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia sy...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67365776

Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders

About this item

Full title

Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders

Publisher

Berlin: Springer

Journal title

Journal of molecular medicine (Berlin, Germany), 2005-01, Vol.83 (1), p.33-38

Language

English

Formats

Publication information

Publisher

Berlin: Springer

More information

Scope and Contents

Contents

Hyperphosphatemia-hyperostosis syndrome (HHS) is a rare autosomal recessive metabolic disorder characterized by elevated serum phosphate levels and repeated attacks of acute, painful swellings of the long bones with radiological evidence of periosteal reaction and cortical hyperostosis. HHS shares several clinical and metabolic features with hyperp...

Alternative Titles

Full title

Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_67365776

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67365776

Other Identifiers

ISSN

0946-2716

E-ISSN

1432-1440

DOI

10.1007/s00109-004-0610-8

How to access this item